InsidersTradesSigma
Track the AYTU BIOSCIENCE, INC share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 21 January 2016 (Acquisition). Among the most active insiders: Disbrow Jarrett. All data is accessible without an account.
Analysts rate AYTU BIOSCIENCE, INC Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
AYTU BIOSCIENCE, INC is a company focused on the development and commercialization of pharmaceutical products and medical devices. It aims to provide innovative solutions to unmet healthcare needs.